Masanori Yasuo Selected Research

Therapeutic Uses

5/2018	Usefulness of the forced oscillation technique in assessing the therapeutic result of tracheobronchial central airway obstruction.
10/2006	Therapeutic effects for hypersensitivity pneumonitis induced by Japanese mushroom (Bunashimeji).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Yasuo Research Topics

Disease

8	Chronic Obstructive Pulmonary Disease (COPD) 07/2021 - 01/2007
8	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2009
6	Immunoglobulin G4-Related Disease 01/2022 - 05/2011
6	Neoplasms (Cancer) 12/2012 - 12/2006
5	Emphysema 05/2021 - 03/2011
5	Sarcoidosis (Schaumann Disease) 09/2020 - 10/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 12/2006
4	Hypoxia (Hypoxemia) 01/2022 - 10/2009
4	Pneumonia (Pneumonitis) 01/2020 - 01/2002
4	Asthma (Bronchial Asthma) 01/2017 - 01/2002
3	Lymphadenopathy 02/2020 - 01/2011
3	Lung Diseases (Lung Disease) 01/2020 - 05/2016
3	Fever (Fevers) 03/2017 - 08/2003
3	Thymoma (Thymic Carcinoma) 06/2010 - 11/2006
2	Altitude Sickness (Mountain Sickness) 01/2023 - 01/2022
2	Idiopathic Interstitial Pneumonias 01/2022 - 01/2014
2	COVID-19 12/2021 - 01/2020
2	Inflammation (Inflammations) 05/2021 - 03/2009
2	Airway Obstruction (Choking) 01/2020 - 05/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2019 - 01/2007
2	Respiratory Insufficiency (Respiratory Failure) 11/2019 - 01/2010
2	Dyspnea (Shortness of Breath) 07/2018 - 05/2009
2	Adenocarcinoma 01/2015 - 04/2009
2	Pulmonary Emphysema 01/2013 - 01/2012
2	Pleural Effusion (Pleural Effusions) 01/2011 - 04/2009
2	Pathologic Constriction (Stenosis) 01/2011 - 01/2007
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 12/2007 - 10/2006
2	Sepsis (Septicemia) 04/2007 - 01/2007
2	Tracheal Stenosis 01/2007 - 09/2006
1	Nausea 01/2022
1	Diarrhea 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Castleman Disease (Castleman's Disease) 07/2021
1	Heart Failure 11/2019
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 11/2019
1	Tracheoesophageal Fistula 01/2018
1	Necrosis 01/2018
1	Fistula 01/2018
1	Fibrosis (Cirrhosis) 03/2017
1	Renal Insufficiency (Renal Failure) 03/2017
1	Edema (Dropsy) 03/2017
1	Thrombocytopenia (Thrombopenia) 03/2017

Drug/Important Bio-Agent (IBA)

6	Immunoglobulin G (IgG)IBA 01/2022 - 01/2006
4	LigandsIBA 09/2020 - 01/2019
4	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 11/2006
4	Cisplatin (Platino)FDA LinkGeneric 06/2010 - 11/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2011
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2011
3	Carbon MonoxideIBA 07/2021 - 01/2007
3	CC ChemokinesIBA 09/2020 - 01/2019
3	CytokinesIBA 09/2020 - 10/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2011 - 09/2006
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
2	SmokeIBA 05/2021 - 01/2019
2	InterleukinsIBA 05/2021 - 12/2012
2	Oxidants (Oxidizing Agents)IBA 01/2019 - 01/2012
2	Therapeutic UsesIBA 05/2018 - 10/2006
2	Pemetrexed (MTA)FDA Link 01/2018 - 12/2010
2	Bronchodilator Agents (Bronchodilators)IBA 01/2016 - 01/2007
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 04/2009
2	SteroidsIBA 05/2011 - 01/2002
2	Vinorelbine (Navelbine)FDA LinkGeneric 12/2010 - 05/2009
2	Gemcitabine FDA Link 12/2010 - 07/2009
2	PlatinumIBA 06/2010 - 11/2006
2	Platinum Compounds (Compounds, Platinum)IBA 06/2010 - 07/2007
2	Docetaxel (Taxotere)FDA Link 07/2009 - 05/2009
1	PPAR alphaIBA 01/2023
1	Vascular Endothelial Growth FactorsIBA 01/2022
1	nintedanibIBA 01/2022
1	EnzymesIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 12/2021
1	NitrogenIBA 12/2021
1	Interleukin-6 (Interleukin 6)IBA 07/2021
1	Interleukin-33IBA 05/2021
1	Pancreatic Elastase (Elastase)IBA 05/2021
1	Fluorine-18IBA 02/2020
1	Receptor for Advanced Glycation End ProductsIBA 01/2020
1	GoldIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Chemokine CCL1IBA 01/2019
1	Acrolein (Aqualin)IBA 01/2019
1	ChemokinesIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Reticulin (Reticular Fiber)IBA 03/2017
1	Carcinoembryonic AntigenIBA 01/2017
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2017

Therapy/Procedure

10	Therapeutics 12/2021 - 12/2006
9	Drug Therapy (Chemotherapy) 05/2012 - 11/2006
3	Artificial Respiration (Mechanical Ventilation) 07/2018 - 10/2009
3	Radiofrequency Ablation 01/2015 - 04/2010
2	Lung Transplantation 11/2019 - 01/2014
2	Catheters 04/2010 - 01/2007
2	Salvage Therapy 07/2007 - 11/2006
2	Argon Plasma Coagulation 01/2007 - 09/2006
1	Extracorporeal Membrane Oxygenation 01/2020
1	Mechanical Ventilators (Ventilator) 11/2019
1	Thoracoplasty 07/2018